No Detail Found!

Structure-based virtual screening and molecular docking of drugs against the SARS-CoV-2 spike protein-ACE2 receptor complex

Author(s)
Irshad Ahmad Institute of Basic Medical Sciences, Khyber Medical University,Peshawar,Pakistan
Muhammad Ali Institute of Basic Medical Sciences, Khyber Medical University,Peshawar,Pakistan
Roshan Ali Institute of Basic Medical Sciences, Khyber Medical University,Peshawar,Pakistan
Nighat Nawaz Department of Chemistry, Islamia College Peshawar,Peshawar,Pakistan
Simon G Patching School of Biomedical Sciences, University of Leeds,Leeds,UK
Abstract
The agent responsible for the COVID-19 pandemic was the newly discovered coronavirus SARS-CoV-2. A trimeric spike protein on the SARS-CoV-2 virion binds to the ACE2 receptor on host cells. In this study we performed a structure-based virtual screening and molecular docking of existing drugs against a high-resolution structure of the SARS-CoV-2 spike protein-ACE2 receptor complex. The 2.5-Å crystal structure of the C-terminal domain of the SARSCoV-2 spike protein (residues 319-541) in complex with human ACE2 (SARS-CoV-2-S-CTD/hACE2) (PDB ID: 6LZG) was used as the target for screening 4,374 FDA-approved drugs from the ZINC15 database using PyRx software. Molecular docking was performed using BIOVIA Discovery Studio Visualizer. The top twenty highest affinity drugs had binding energies of -7.0 to -8.8 kcal/mol. The highest affinity drug was the selective vasopressin V2-receptor antagonist Tolvaptan, for which molecular docking identified drug-amino acid residue interactions with ACE2. Other drugs displaying binding energies better than -8.0 kcal/mol were Nizoral, Amaryl, Accolate, Sorafenib, Glipizide and Azelastine. The predicted interactions of these highest affinity drugs with residues in ACE2 were at positions that could disrupt the spike protein-ACE2 complex, so these drugs have the potential to be repurposed as inhibitors of the SARSCoV-2 virus.
Publication Details
Page(s) 1531-1538
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
therapeutics, Coronavirus, Infections, drug discovery, molecular docking simulation
0

Citations

0

Downloads

83

Views